Literature DB >> 15930259

Human T-cell leukemia virus type I at age 25: a progress report.

Masao Matsuoka1, Kuan-Teh Jeang.   

Abstract

It has been 25 years since the discovery of human T-cell leukemia virus type I (HTLV-I) and its role in adult T-cell leukemia. Here, in brief, we review the current state of our understanding of HTLV-I epidemiology, viral biology, pathogenesis, and treatment. We discuss how HTLV-I may transform cells through destabilization of cellular genomic integrity and induction of cellular tolerance for chromosomal errors.

Entities:  

Mesh:

Year:  2005        PMID: 15930259     DOI: 10.1158/0008-5472.CAN-05-0559

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice.

Authors:  Paola Miyazato; Jun-ichirou Yasunaga; Yuko Taniguchi; Yoshio Koyanagi; Hiroaki Mitsuya; Masao Matsuoka
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats.

Authors:  Yeung-Tung Siu; King-Tung Chin; Kam-Leung Siu; Elizabeth Yee Wai Choy; Kuan-Teh Jeang; Dong-Yan Jin
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling.

Authors:  Jean-Claude Twizere; Jean-Yves Springael; Mathieu Boxus; Arsène Burny; Franck Dequiedt; Jean-François Dewulf; Julie Duchateau; Daniel Portetelle; Patrice Urbain; Carine Van Lint; Patrick L Green; Renaud Mahieux; Marc Parmentier; Luc Willems; Richard Kettmann
Journal:  Blood       Date:  2006-09-21       Impact factor: 22.113

Review 4.  Human T-cell leukemia virus-associated malignancy.

Authors:  Amanda R Panfil; Michael P Martinez; Lee Ratner; Patrick L Green
Journal:  Curr Opin Virol       Date:  2016-08-31       Impact factor: 7.090

5.  Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.

Authors:  Maki Miyazaki; Jun-Ichirou Yasunaga; Yuko Taniguchi; Sadahiro Tamiya; Tatsutoshi Nakahata; Masao Matsuoka
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

6.  A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells.

Authors:  Junko H Ohyashiki; Ryoko Hamamura; Chiaki Kobayashi; Yu Zhang; Kazuma Ohyashiki
Journal:  Adv Appl Bioinform Chem       Date:  2008-10-30

7.  Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways.

Authors:  Emmanuel Agbottah; Wen-I Yeh; Reem Berro; Zachary Klase; Caitlin Pedati; Kyleen Kehn-Hall; Weilin Wu; Fatah Kashanchi
Journal:  AIDS Res Ther       Date:  2008-06-10       Impact factor: 2.250

8.  Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State.

Authors:  Masachika Senba; Kioko Kawai; Naoki Mori
Journal:  Leuk Res Treatment       Date:  2011-12-01

9.  Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective.

Authors:  Nishat Aliya; Saifur Rahman; Zafar K Khan; Pooja Jain
Journal:  Leuk Res Treatment       Date:  2012-02-09

10.  Severe hypercalcaemia and lymphoma in an HTLV-1 positive Jamaican woman: a case report.

Authors:  Veronica Lyell; Elham Khatamzas; Theresa Allain
Journal:  J Med Case Rep       Date:  2007-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.